ABSTRACT
Objective To 1) develop and evaluate a machine learning model incorporating gait and physical activity to predict medial tibiofemoral cartilage worsening over two years in individuals without or with early knee osteoarthritis and 2) identify influential predictors in the model and quantify their effect on cartilage worsening.
Design An ensemble machine learning model was developed to predict worsened cartilage MRI Osteoarthritis Knee Score at follow-up from gait, physical activity, clinical and demographic data from the Multicenter Osteoarthritis Study. Model performance was evaluated in repeated cross-validations. The top 10 predictors of the outcome across 100 held-out test sets were identified by a variable importance measure statistic, and their marginal effect on the outcome was quantified by g-computation.
Results Of 947 legs in the analysis, 14% experienced medial cartilage worsening at follow-up. The median (2.5th-97.5th percentile) AUC across the 100 held-out test sets was 0.73 (0.65-0.79). Presence of baseline cartilage damage, higher Kellgren-Lawrence grade, greater pain during walking, higher lateral ground reaction force impulse, greater time spent lying, and lower vertical ground reaction force unloading rate were associated with greater risk of cartilage worsening.
Conclusions An ensemble machine learning approach incorporating gait, physical activity, and clinical/demographic features showed good performance for predicting cartilage worsening over two years. While identifying potential intervention targets from the model is challenging, these results suggest that lateral ground reaction force impulse, time spent lying, and vertical ground reaction force unloading rate should be investigated further as potential early intervention targets to reduce medial tibiofemoral cartilage worsening.
What are the findings?
Machine learning models predicted cartilage worsening in persons without or with early knee osteoarthritis from gait, physical activity, and clinical and demographic characteristics with a median AUC of 0.73 across 100 held-out test sets.
High lateral ground reaction force impulse, more time spent lying, and low vertical ground reaction force unloading rate were associated with increased risk of cartilage worsening over two years.
How might it impact on clinical practice in the future?
Gait and physical activity are some of the only modifiable risk factors for knee osteoarthritis; this study identified three potential intervention targets to slow early knee osteoarthritis progression.
Competing Interest Statement
NAS reports personal fees from Tenex Health and grants from Pacira Bioscience, Inc., outside of the submitted work. AG is shareholder of BICL, LLC and consultant to Pfizer, AstraZeneca, Novartis, TissueGene, Regeneron and MerckSerono. FWR is shareholder of BICL, LLC and consultant to Grünenthal. All other authors have no competing interests to report.
Funding Statement
MOST is comprised of four cooperative grants [D.T. Felson (BU): AG18820, J.C. Torner (UI): AG18832, C.E. Lewis (UAB): AG18947, and M.C. Nevitt (UCSF): AG19069] funded by the National Institutes of Health (NIH), a branch of the Department of Health and Human Services, and conducted by MOST study investigators. Research reported in this publication was also supported under award numbers F32AR076907 (K.E. Costello), P30AR072571 (D.T. Felson), 1UL1TR001430 (D.T. Felson), R21AR074578 (S.R. Jafarzadeh), R03AG060272 (S.R. Jafarzadeh), K23AR063235 (C.L. Lewis), R01HL159620 (V.B. Kolachalama), R21CA253498 (V.B. Kolachalama), and K01AR069720 (D. Kumar) from the National Institutes of Health and 17SDG33670323 (V.B. Kolachalama) and 20SFRN35460031 (V.B. Kolachalama) from the American Heart Association. K.E. Costello was also supported by an Investigator Award from the Rheumatology Research Foundation. This manuscript was prepared using MOST data and does not necessarily represent the official views of MOST investigators or the National Institutes of Health. The MOST publications committee reviewed this manuscript before submission. The National Institutes of Health was not involved in study design, collection, analysis or interpretation of data, or the decision to submit this manuscript for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for the Multicenter Osteoarthritis Study was obtained at each of the four core sites (Boston University, University of Alabama at Birmingham, University of California San Francisco, University of Iowa) and all participants provided informed consent prior to participating.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Updated the scaling/centering step such that it is performed prior to splitting the data into train and test sets; Pearson correlations replaced with Spearman correlations; clarity improved throughout
Data Availability
Data are available in a public, open access repository. Data from the Multicenter Osteoarthritis Study are available through the National Institute on Aging Research Biobank: https://agingresearchbiobank.nia.nih.gov/. Public use datasets from the 144- and 168-month visits of the Multicenter Osteoarthritis Study will be available at this website in 2023.
